Clinical trial

Telmisartan and Hydrochlorothiazide Antihypertensive Treatment Study in High Sodium Intake Population

NCT02255253

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-10-01

PhaseNA

Study timeline

Study start (unknown)2014-10-01Date precision: month

Registry last updated2015-03-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertensionunresolved

Interventions

TelmisartanDRUG · verified · RxNorm: telmisartan

HydrochlorothiazideDRUG · verified · RxNorm: hydrochlorothiazide

Sponsors & collaborators

The George Institute for Global Health, Chinalead sponsor

Peking University People's Hospitalcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02255253 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.